Clinical Trials Directory

Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients

GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study

1st Line Durvalumab in PS 2 NSCLC Patients

Prevention of Celiac Disease in Skåne

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients

Dietary Management of Gestational Diabetes

ANIMATE: Phase II Study of Nivolumab Monotherapy for Relapsed/Refractory Hodgkin Lymphoma

Sex Differences in Chronic Kidney Disease

Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis

Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome

Psoriatic Arthritis and Psoriasis Treatment Decision Aid

TITRE III: Influenza B Immunogenicity Investigation

Factors Affecting Newborn Body Composition and Later Health in Helsinki Birth Cohort 2018-2022

Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer

NOVOCART 3D Treatment Following Microfracture Failure

Peer Approaches to Lupus Self-management

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

TReatment of Pulmonary Hypertension Group II Study

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients

Walking Rehabilitation After Spinal Cord Injury: Locomotor Training Using Adaptive Robotics

Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

Post-Authorization Long-Term Safety Study of LUTATHERA

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment

Preventing Asthma in High Risk Kids

A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)

Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

Personalized Exercise Oncology

Obinutuzumab in Marginal Zone Lymphoma

Safety and Efficacy of the ANTHEM™ CR Total Knee System